Magnetic resonance imaging pattern in natalizumab‐associated progressive multifocal leukoencephalopathy

Abstract

Attention to characteristic MRI patterns, especially the presence of contrast enhancement, and the subcortical location may have utility in screening and early diagnosis of PML in natalizumab-treated MS patients.